NCT07167017

Brief Summary

The goal of this observational cross-sectional study is to study the results of karyotyping analysis for children presented with congenital anomalies and developmental delay aged 1 month to 12 years, the need for further genetic tastings and identification of parents who are carrier of balanced chromosomal translocations. The main question it aims to answer: What the is the incidence of congenital anomalies tested by karyotyping and the type of chromosomal abnormalities causing the clinical features. Researcher will take detailed clinical history, physical examination and developmental assessment for children and interpret karyotyping results. For participants data will be collected regarding:

  1. 1.History will be taken including demographic data of child age, parental age, consanguinity and relevant family history and developmental history.
  2. 2.Clinical examination for any fascial dysmorphism, congenital heart disease, skeletal deformities, renal anomalies or any associated features.
  3. 3.Clinical assessment of developmental milestones.
  4. 4.Investigations done including laboratory tests, ultrasound scan, x-rays, CT scan, echocardiography or any other investigation.
  5. 5.Karyotyping results detected if aneuploidy or structural abnormality including chromosomal deletions, duplications, translocations or inversions.
  6. 6.Other genetics tests done including Comparative microarray, FISH (Fluorescence in Situ Hybridization), and WES (Whole Exome Sequencing).
  7. 7.If parental karyotyping for suspected translocations was done.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Nov 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Nov 2025Dec 2026

First Submitted

Initial submission to the registry

September 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 11, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 3, 2025

Last Update Submit

September 3, 2025

Conditions

Keywords

karyotypingcongenital anomaliesdevelopmental delay

Outcome Measures

Primary Outcomes (1)

  • Result Of Karyotyping in Pediatric Patients with Congenital Anomalies and Developmental Delay at Assiut University Children Hospital

    To detect the incidence of congenital anomalies and developmental delay tested with karyotyping and to detect karyotyping findings of chromosomal numerical or structural abnormalities that cause clinical features.

    November 2025-December 2026

Secondary Outcomes (1)

  • Result Of Karyotyping in Pediatric Patients with Congenital Anomalies and Developmental Delay at Assiut University Children Hospital

    November 2025-December 2026

Eligibility Criteria

Age1 Month - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children aged between 1 months, and 12 years presented at Assiut university hospital with congenital anomalies and developmental delay either global developmental delay or affecting one domain (cognitive, motor, speech and language or social) during the year 2025-2026.

You may qualify if:

  • All patients aged between 1 month to 12 years old who are presented with morphologic congenital anomalies associated with developmental delay either global DD or isolated developmental domain (cognitive, motor, speech and language or social) who are tested for chromosomal abnormalities

You may not qualify if:

  • Any patient aged between 1 month and 12 years old who is presented with Developmental Delay and congenital anomalies who didn't undergo karyotyping or other genetic testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Congenital AbnormalitiesLearning Disabilities

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Mohamed Mahrous Mohamed, Professor of pediatrics

    Assiut University

    STUDY DIRECTOR
  • Mohamed Abobakr Mohamed, Lecturer of pediatr

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master degree student

Study Record Dates

First Submitted

September 3, 2025

First Posted

September 11, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 11, 2025

Record last verified: 2025-09